$4.39+0.06|(+1.39%)
52W H: 7.0852W L: 1.17Beta: 1.57

About Treace Medical Concepts, Inc

Frequently Asked Questions

What is the 52-week range for TMCI?

The 52-week high is $7.08 and the 52-week low is $1.17.

What is the P/E ratio for TMCI?

The P/E ratio data is currently unavailable.

What is the dividend yield for TMCI?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -74.06%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -28.99%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 1.79.

Analyst Recommendation Trends

Wall Street analyst consensus for TMCI over the last few months:

2026-09-01
Buy: 1
S.Buy: 0
Hold: 5
Sell: 2
2026-08-01
Buy: 1
S.Buy: 0
Hold: 5
Sell: 2
2026-07-01
Buy: 1
S.Buy: 0
Hold: 5
Sell: 2
2026-06-01
Buy: 1
S.Buy: 0
Hold: 5
Sell: 2

Latest TMCI News

Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced five-year ALIGN3D results on September 17, adding longer-term evidence for the Lapiplasty bunion-correction procedure. The final analysis included 137 of 173 treated patients, or approximately 79% of the original group. Reported radiographic recurrence was 0.8% when defined as a hallux valgus angle greater than 20 degrees and 5.3% using […]

Yahoo9/23/2026

Treace Medical Looks Unlikely To Recover, A Founder-Led Broken Growth Story

Treace Medical outlook: revenue declines, Lapiplasty losing share, margins compressing, and EBITDA delayed. Click for more on TMCI stock.

SeekingAlpha9/20/2026

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

PONTE VEDRA, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced the presentation of the results from three clinical studies at the American Orthopaedic Foot & Ankle Society (“AOFAS”) Annual Meeting in Seattle, Washington. The presentations include data on the milestone 5-year ALIGN3D® Lap

Yahoo9/17/2026

Treace Medical Presents 5-Year ALIGN3D Data Showing 0.8% Recurrence Rate Alongside MTA3D And SPRINT Clinical Results At AOFAS 2026

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle

Benzinga9/17/2026

Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?

Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Yahoo9/17/2026

Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

New product offerings extend bunion market leadership and accelerate penetration into new foot & ankle market adjacenciesPONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle conditions, today announced it will highlight multiple new product innovations and present clinical data at the American Orthopaedic

Yahoo9/15/2026

Related Stocks (Peers)

Companies operating in similar sectors to TMCI:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-24Treace John T.+11,000$4.3392$47,731
2026-08-21Treace John T.+5,000$4.3495$21,748
2026-08-20Treace John T.+39,944$4.4356$177,176
2026-08-09Scanlan Sean F.-9,814--
2026-08-09Hair Mark-37,102--
2026-08-09Elder Scot Michael-16,253--
2026-06-11Treace John T.+9,891$4.0423$39,982
2026-06-11Treace John T.+22,887$4.0434$92,541
2026-06-10Treace John T.+14,715$4.024$59,213
2026-06-10Treace John T.+29,430$4.024$118,426
2026-06-01Treace John T.+50,000$3.5583$177,915
2026-05-28Treace John T.+61,202$3.0199$184,824
2026-05-27Treace John T.+49,810$2.8747$143,189
2026-05-26Treace John T.+4,508$2.7897$12,576
2026-05-19Jain Deepti+30,000--
2026-05-19Hanna Betsy+30,000--
2026-05-19Berry Lance A+30,000--
2026-05-19Kiernan Jane E+30,000--
2026-05-19HAMILTON LAWRENCE W+30,000--
2026-05-19BAKEWELL JOHN K+30,000--
2026-05-14Treace John T.+61,750$2.6153$161,495
2026-05-13Treace John T.+49,013$2.4592$120,533
2026-05-12Treace John T.+43,000$2.1739$93,478
2026-04-17Hair Mark-11,547--
2026-04-01Hair Mark+100,000--
2026-03-10Elder Scot Michael-1,675--
2026-03-10Scanlan Sean F.-1,396--
2026-03-10Treace John T.-5,021--
2026-03-10Hair Mark-3,695--
2026-03-08Elder Scot Michael-175--
2026-03-08Scanlan Sean F.-401--
2026-03-08Treace John T.-2,062--
2026-03-08Hair Mark-964--
2026-02-10Scanlan Sean F.-16,875--
2026-02-10Scanlan Sean F.+16,875$1.05$17,719
2026-01-22Guglielmino Gaetano+150,000--
2026-01-22Elder Scot Michael+262,500--
2026-01-22Elder Scot Michael-9,451--
2026-01-22Hair Mark+375,000--
2026-01-22Hair Mark-17,037--
2026-01-22Scanlan Sean F.+262,500--
2026-01-22Treace John T.+250,000--
2026-01-22Treace John T.-14,254--
2026-01-21Scanlan Sean F.+53,500--
2026-01-21Scanlan Sean F.+53,500$0.72$38,520
2026-01-10Hair Mark-8,719--
2026-01-10Elder Scot Michael-4,544--
2026-01-10Treace John T.-13,219--
2025-12-01Guglielmino Guy-2,009--
2025-12-01Guglielmino Guy-20,090--
2025-10-25Elder Scot Michael-984--
2025-10-24Scanlan Sean F.-208--